The largest database of trusted experimental protocols

41 protocols using fitc anti mouse cd3

1

CD8+ T cell Phenotyping in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens of vaccinated or control mice were isolated and single-cell suspensions made as outlined above. For dextramer analysis, 1 x 106 splenocytes in FACs buffer (PBS + 5% FBS) were then stained with 5 μL SIINFEKL-H2-Kb-PE dextramer (Immudex, Copenhagen, Denmark) for 10 minutes at RT in the dark. After 10 minutes, a staining cocktail of anti-mouse-CD3-FITC (BioLegend) and anti-mouse-CD8α-PerCP/Cy5.5 (Cat# 100734, BioLegend) was added to each sample. Samples were incubated for another 20 minutes at 4°C. For tetramer staining, 1 x 106 splenocytes in FACs buffer were stained with 1 μL SIINFEKL-H2-Kb-PE tetramer (MHC Tetramer Production Core, BCM, Houston, TX), anti-mouse-CD3-FITC, anti-mouse-CD4-APC-Cy7 (Cat# 100414, BioLegend), and anti-mouse-CD8α-PerCP/Cy5.5 for 1 hour at 4°C. Stained cells were analyzed on a Gallios flow cytometer (Beckman Coulter).
+ Open protocol
+ Expand
2

Comprehensive Immunological Profiling of Tumor Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
4T1, H22, HepG2, NIH‐3T3, and Panc02 were purchased from BeNa Culture Collection, China. Anti‐mouse PD‐1 antibody (PD‐1 Ab, BE0146‐100 mg) was purchased from Bio X Cell. Anti‐human PD‐1 Ab was obtained as a gift from Livzon Pharmaceutical Group Inc., China. Flow cytometry antibodies included PE anti‐mouse CD274 (B7‐H1, PD‐L1) (124308), APC/Cyanine7 anti‐mouse CD45 (103132), FITC anti‐mouse CD3 (100204), Brilliant Violet 421 anti‐mouse CD4 (100563), PE/Cy7 anti‐mouse CD8a (100722), PE anti‐mouse IFN‐γ (505808), Alexa Fluor 647 anti‐human/mouse Granzyme B (515406), APC anti‐mouse Ki‐67 (652406), PE anti‐mouse/human CD44 (103008), PE anti‐mouse Ly‐6G/Ly‐6C (Gr‐1) (108407), APC/Cyanine7 anti‐mouse/human CD11b (101226), Brilliant Violet 421 anti‐mouse F4/80 (123137), PE anti‐mouse CD86 (105008), PE/Cy7 anti‐mouse CD206 (MMR) (141720), Alexa Fluor 647 anti‐mouse FOXP3 (126408), APC anti‐mouse CD49b (pan‐NK cells) (108910), PE anti‐mouse CD25 (102008), PE anti‐mouse/human CD44 (103008), APC anti‐mouse CD62L (104412), Zombie Aqua Fixable Viability Kit (423102), Cell Activation Cocktail (with Brefeldin A) (423304), True‐Nuclear Transcription Factor Buffer Set (424401), and Intracellular Staining Permeabilization Wash Buffer (10X) (421002) were purchased from BioLegend.
+ Open protocol
+ Expand
3

Quantifying T Cell Populations in Wound Healing

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to analyse the CD4+ and CD8 + T cell content in mouse spleen and lymph nodes during wound healing, the spleen and lymph nodes of the sacrificed mice on day 7 were removed in a sterile environment, washed with PBS, and then ground on a 0.75-μm sieve. The obtained cell suspension was washed with PBS, centrifuged at 1000 rpm for 5 min and then lysed with red blood cell lysis buffer (Solarbio). The cells were stained with cell staining buffer (Biolegend), incubated with antibodies of APC anti-mouse CD4 (BioLegend), brilliant violet 510TM anti-mouse CD8 (BioLegend), FITC anti-mouse CD3 (BioLegend) and finally analysed by flow cytometry (MoFlo High-Performance Cell Sorter, Beckman).
+ Open protocol
+ Expand
4

AURKA and BET Bromodomain Inhibitors in MDA-MB-231 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
AURKA inhibitors VX‐680 and MLN8237 and bromodomain and extra‐terminal (BET) bromodomain inhibitor JQ1 were obtained from Selleck Chemicals (Houston, TX, USA) and dissolved in dimethyl sulfoxide (DMSO). MDA‐MB‐231 cells were treated with 0.1, 0.2, and 0.4 μmol/L VX‐680 and 0.1, 0.2, 0.4, and 0.8 μmol/L MLN8237 for 24 h. MDA‐MB‐231 cells with NLS‐AURKA were treated with 1 and 5 μmol/L JQ1 for 48 h for Western blotting detection. Antibodies against AURKA and phospho‐AURKA (T288) were purchased from Sigma‐Aldrich (St. Louis, MO, USA). Glyceraldehyde 3‐phosphate dehydrogenase (GAPDH), goat anti‐mouse IgG‐horse radish peroxidase (HRP), and goat anti‐rabbit IgG‐HRP were obtained from Cell Signaling (Danvers, MA, USA). c‐Myc was purchased from Santa Cruz Biotechnology (Dallas, TX, USA). PD‐L1 was obtained from Abcam (Cambridge, MA, USA). TruStain FcX™ anti‐mouse CD16/32, PerCP anti‐mouse CD45, FITC anti‐mouse CD3, PE anti‐mouse CD4, APC anti‐mouse CD8a, and PE anti‐mouse CD69 used in flow cytometric analysis were purchased from Biolegend (San Diego, CA, USA). PE anti‐human PD‐L1 and its isotype control PE anti‐human IgGk1 were obtained from BD Pharmingen (San Diego, CA, USA).
+ Open protocol
+ Expand
5

Immune Cell Profiling of MC38 Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the end of the experiment, excised MC38 tumors from mice treated with CBPA (10 mg/kg) or the vehicle control were digested into single-cell suspensions. Cells were washed, resuspended in FACS buffer, and used as antibodies against surface antigen staining for 30 min at 4 °C with FITC anti-mouse CD3 (Cat. 100203, BioLegend, San Diego, CA), PE anti-mouse CD4 (Cat. 100407, BioLegend, San Diego, CA), and PE anti-mouse CD8 (Cat. 100707, BioLegend, San Diego, CA). Cells were then fixed and permeabilized, stained for perforin (Cat. 154303, BioLegend, San Diego, CA) and granzyme B (Cat. 396413, BioLegend, San Diego, CA), and analyzed by flow cytometry.
+ Open protocol
+ Expand
6

Mouse MOG35-55 Peptide-Induced Neuroinflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat MOG35–55 peptides were purchased from Biosynth International (Naperville, IL, USA) and the purity of the peptide was >95%. The sequence of MOG35–55 was MEVGWYRSPFSRVVHLYRNGK. FITC anti-mouse CD3, PE/Cy7 anti-mouse CD4, APC/Cy7 anti-mouse CD44, PerCP/Cy5.5 anti-mouse CD11b antibodies, and LEAF Purified anti-mouse IL-6 were purchased from BioLegend (San Diego, CA,USA). Alexa Fluor700 anti-mouse CD45.2, PE anti-mouse CD69, APC anti-mouse CD25, PE anti-mouse IL-17A, and APC anti-mouse IFN-γ antibodies were purchased from eBioscience (San Diego, CA, USA). PE/Cy5 anti-mouse CD8α antibodies were purchased from BD Pharmingen (Basel, Switzerland). Goat anti-mouse ionized calcium-binding adaptor molecule-1 (IBA1) antibody was obtained from abcam (Cambridge, UK). Rat anti-mouse CD45, Rabbit anti-mouse CCL-2 antibody, and CCL-2 (rat recombinant) were purchased from AbD Serotec (Raleigh, NC, USA). Rabbit anti-mouse CCR2 antibody was purchased from Abcam (Cambridge, UK). 2-((1-benzyl-indazol-3-yl) methoxy)-2-methyl propionic acid (Bindarit) was synthesized by and obtained from Angelini (Angelini Research Center-ACRAF, Italy).
+ Open protocol
+ Expand
7

Identification of Breast Cancer Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For detecting only BCSCs in cancers, cancer cells were stained with specific marker proteins using antibodies such as FITC anti-CD44 and APC anti-CD24 (BD, San Jose, CA, USA) to define CD44+/CD24-BCSCs. Single-cell suspensions were prepared from mouse tumor tissues or TDLNs to analyze the T-cells. The processes of tissue sample preparation are described in “Subcutaneous tumor and TDLN resection and sample preparation” section. Cells were stained with specific antibodies as APC anti-mouse CD8a, APC anti-mouse CD4, and FITC anti-mouse CD3 (BioLegend, San Diego, CA, USA) to define CD8+/CD3 + cytotoxic T-cells or CD4+/CD3 + helper T-cells. The samples were analyzed by flow cytometry (Accuri C6, BD Biosciences, East Rutherford, NJ, USA).
+ Open protocol
+ Expand
8

Quantifying Tumor Cell Surface PD-L1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure PD­L1 levels on the cell surface of tumour cells treated with vehicle, cisplatin, radiation, JQ1, IFN‐γ (20 ng/ml,24 PeproTech), or the combinations for the different time periods were trypsinized and harvested for staining with streptavidin‐phycoerythrin (PE)‐conjugated anti‐human PD‐L1(329706, Biolegend). Tumour tissues were collected, cut into small pieces, digested with a mixture of collagenase, DNase and hyaluronidase for preparing single‐cell suspension and then treated with Cell Stimulation Cocktail (00‐4975‐03, eBioscience) as instructed. Cells were washed, re‐suspended in fluorescence‐activated cell sorting buffer at 4°C and then stained with fluorescent‐conjugated antibodies and appropriate isotype controls for multicolor flow cytometry. For cell surface staining, the following antibodies were used: fluorescein isothiocyanate (FITC) anti‐mouse CD3 (100204, Biolegend), PE/Cy7 anti‐mouse cluster of differentiation 4 (CD4) (100422, Biolegend), APC anti‐mouse CD8 (100712, Biolegend), Brilliant Violet 605 anti‐mouse NK1.1 (108739, Biolegend) and PE anti‐mouse PD‐L1(124308, Biolegend). The collected live single cells were fixed and treated with permeabilization buffer before intracellular staining with Brilliant Violet 421 anti‐mouse IFN‐γ (505830, Biolegend).
+ Open protocol
+ Expand
9

Profiling Tumor Immune Landscape by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD3+CD4+ T cells, CD3+CD8+ T cells and CD3+CD4+FOXP3+ T cells, CD11c +CD86+CD80+ dendritic cells as well as CD45+CD11b+F4/80+CD206+ M2 like macrophage and CD45+CD11b+F4/80+CD86+ M1 like macrophage in the tumor tissues or spleen were isolated and analyzed using flow cytometry. The antibodies involved in the experiment include FITC anti-mouse CD11c Antibody (Biolegend, Cat# 117306, Clone No. N418), PE anti-mouse CD86 Antibody (Biolegend, Cat# 105007, Clone No.GL-1), APC anti-mouse CD80 Antibody (Biolegend, Cat# 104714, Clone No.16-10A1), FITC anti-mouse CD3 (Biolegend, Cat# 100203, Clone No.17A2), PE anti-mouse CD4 (Biolegend, Cat# 100407, Clone No.GK1.5), APCanti-mouseCD8a (Biolegend, Cat# 100712, Clone No.53-6.7), AlexaFluor488 anti-mouse FOXP3 (Biolegend, Cat# 320012, Clone No.150D), FITC anti-mouse/human CD11b Antibody (Biolegend, Cat# 101205, Clone No. M1/70), APC anti-mouse CD45 (Biolegend, Cat# 103112, Clone No.30-F11), PerCP anti-mouse F4/80 Antibody (Biolegend, Cat# 123126, Clone No.BM8) and PE/Cyanine7 anti-mouse CD206 (Bioegend, Cat# 141720, Clone No.C068C2). The antibody concentration was 1:100 diluted with PBS.
IL-2, IL-12p70, TNF-α, and IFN-γ in primary tumors were also examined with ELISA kits. And tumors were stained for immunofluorescence of CD3+CD4+ and CD3+CD8+ proliferated CTLs in 4T1 tumor tissue slices of the primary tumor.
+ Open protocol
+ Expand
10

Radioisotope Production and Cellular Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The radioisotope 211At was produced via 209Bi (α, 2n) 211At reaction through CS-30 cyclotron according to the published protocol [25 (link)]. Bovine serum albumin (BSA), Manganese chloride tetrahydrate (MnCl2·4H2O), and sodium hydroxide (NaOH) were from Sigma-Aldrich. Roswell park memorial institute (RPMI) 1640 medium, penicillin-streptomycin, and fetal bovine serum (FBS) were obtained from Gbico. The cell counting kit-8 (CCK-8) was obtained from Biosharp. The anti-mouse PD-L1 antibody was obtained from BioXcell (clone:10F.9G2). APC anti-mouse CD45(Catalog: 103111), FITC anti-mouse CD3 (Catalog: 100203), BV421™ anti mouse CD4(Catalog: 100437), APC/Cy7 anti-mouse CD8a (Catalog: 100714), PE anti-mouse FOXP3 (Catalog: 126403), FITC anti-mouse CD11c (Catalog: 117305), PE anti-mouse CD86 (Catalog:105007), APC anti-mouse CD80 (Catalog: 104713), PE/Cy7 anti-mouse CD45 (Catalog: 103113), PE anti-mouse CD44(Catalog:103023) and BV421- anti-mouse CD62L (Catalog: 104435) antibodies were obtained from Biolegend, Tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ) ELISA kit was purchased from Multisciences Biotech, Co., Ltd.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!